News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Parschauer Karah Herdman
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 29,532 options to buy
@ $7.12, valued at
$210.3k
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2023 |
4
| Parschauer Karah Herdman (EVP and Chief Legal Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 3,161 shares
@ $45.25, valued at
$143k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2022 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.82, valued at
$96.4k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 15,568 shares
@ $0
Granted 22,727 options to buy
@ $5.46, valued at
$124.1k
|
|
| 12/23/2021 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Granted 19,495 options to buy
@ $20.99, valued at
$409.2k
|
|
| 10/18/2021 |
4
| Parschauer Karah Herdman (EVP and General Counsel) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 310 shares
@ $81.14, valued at
$25.2k
|
|
| 09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $35.09, valued at
$526.4k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 19,313 shares
@ $0 |
|
| 11/02/2020 |
4
| Parschauer Karah Herdman (EVP and General Counsel) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 9,903 shares
@ $100.12, valued at
$991.5k
Exercised 9,903 options to buy
@ $54.5, valued at
$539.7k
|
|
| 10/30/2020 |
4
| Parschauer Karah Herdman (EVP and General Counsel) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 97 shares
@ $100, valued at
$9.7k
Exercised 97 options to buy
@ $54.5, valued at
$5.3k
|
|
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| Parschauer Karah Herdman (EVP and General Counsel) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 2,722 shares
@ $74.715, valued at
$203.4k
|
|
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2020 |
4
| Parschauer Karah Herdman (EVP and General Counsel) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 248 shares
@ $58.57, valued at
$14.5k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 23,458 options to buy
@ $10.19, valued at
$239k
|
|
| 10/29/2019 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $10.23, valued at
$153.5k
Granted 20,000 options to buy
@ $10.23, valued at
$204.6k
|
|
| 10/16/2019 |
4
| Parschauer Karah Herdman (EVP and General Counsel) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,434 shares
@ $0 |
|
| 07/17/2019 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 26,163 options to buy
@ $15.99, valued at
$418.3k
|
|
|
|
|